Finch Therapeutics Group, Inc. (FNCH) Operating Lease, Right-of-Use Asset USD 2016 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Finch Therapeutics Group, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from 2016 to 2024.
  • Finch Therapeutics Group, Inc. Operating Lease, Right-of-Use Asset for the quarter ending March 31, 2024 was $26 M, a 18.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $26 M -$5.81 M -18.3% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $26.6 M -$6.17 M -18.8% Dec 31, 2023 10-Q 2024-05-10
Q3 2023 $26.6 M -$13.8 M -34.1% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $27.3 M -$13.9 M -33.7% Jun 30, 2023 10-Q/A 2023-08-11
Q1 2023 $31.8 M +$27 M +562% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $32.8 M +$27.7 M +548% Dec 31, 2022 10-K 2024-03-25
Q3 2022 $40.4 M +$35.1 M +661% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $41.2 M +$35.7 M +649% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $4.81 M -$989 K -17.1% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $5.05 M +$5.05 M Dec 31, 2021 10-K 2023-03-23
Q3 2021 $5.3 M Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $5.5 M Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $5.8 M Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $0 Dec 31, 2020 10-K 2022-03-31
Q1 2016 $5.8 M Feb 29, 2016 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.